Xueting Wan
Mengyao Song
Aiyun Wang
Yang Zhao
Zhonghong Wei
Yin Lu
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
- 1Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
- 2Jiangsu Joint International Research Laboratory of Chinese Medicine and Regenerative Medicine, Nanjing, China
- 3Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine (TCM) Prevention and Treatment of Tumor, Nanjing University of Chinese Medicine, Nanjing, China
- 4Department of Biochemistry and Molecular Biology, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, China
A Corrigendum on:
Microbiome Crosstalk in Immunotherapy and Antiangiogenesis Therapy
By Wan X, Song M, Wang A, Zhao Y, Wei Z and Lu Y (2021) Front. Immunol. 12:747914. doi: 10.3389/fimmu.2021.747914
In the published article, there was an error in affiliation 3. Instead of “Key Laboratory of Drug Metabolism and Pharmacokinetics, State Key Laboratory of Natural Medicine, China Pharmaceutical University, Nanjing, China”, it should be “Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine (TCM) Prevention and Treatment of Tumor, Nanjing University of Chinese Medicine, Nanjing, China”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: microbiome, immunotherapy, immune checkpoint, angiogenesis, prebiotics, Chinese medicine
Citation: Wan X, Song M, Wang A, Zhao Y, Wei Z and Lu Y (2022) Corrigendum: Microbiome Crosstalk in Immunotherapy and Anti-Angiogenesis Therapy. Front. Immunol. 13:887775. doi: 10.3389/fimmu.2022.887775
Received: 02 March 2022; Accepted: 01 April 2022;
Published: 21 April 2022.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 Wan, Song, Wang, Zhao, Wei and Lu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yin Lu, bHV5aW5ncmVlbkBuanVjbS5lZHUuY24=; Zhonghong Wei, d3poMTIyNUBuanVjbS5lZHUuY24=
†These authors contributed equally to this work